| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | 15Five | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $94.69M | Series C | 7/21/2022 | $39.04M | $535.4M | $9.70 | Quad Partners, N47, Origin Ventures, Edison Partners, Matrix, Point Nine, New Ground Ventures, LAUNCH, ServiceNow Ventures | ||||
 | 98point6 | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $267.22M | Series E | 10/15/2020 | $134.21M | $548.43M | $6.59 | L Catterton, Activant Capital, Goldman Sachs | ||||
 | Anumana | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $185.3M | Series C | 4/24/2025 | $95.4M | $568.24M | $5.16 | Boston Scientific Corporation, Matrix Capital, Mayo Clinic, Matrix Partners, NTTVC | ||||
 | AppOmni | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $122.95M | Series C | 6/6/2022 | $70M | $515.74M | $3.11 | Thoma Bravo, Scale Venture Partners, Salesforce Ventures, ClearSky, Costanoa Ventures | ||||
 | Axtria | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $159.97M | Series E | 5/13/2021 | $100.1M | $920.88M | $9.53 | Bain Capital Tech Opportunities | ||||
 | Bestow | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $376.58M | Series D | 5/13/2025 | $51.51M | $887.92M | $11.82 | Goldman Sachs, Smith Point Capital | ||||
 | BloomTech | Education E-Learning | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $346.3M | Series D-3 | 2/14/2024 | $1.86M | $555.42M | $7.59 | Undisclosed Investors | ||||
 | Calyxo | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $155.79M | Series F | 4/14/2026 | $40.1M | $658.2M | $8.82 | Ally Bridge Group, Janus Henderson Investors, Questa Capital, Avidity Partners, CRG | ||||
 | Celigo | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $263.78K | -- | 1 | Not available | -- | -- | $84.31M | Series C | 12/8/2021 | $47.92M | $566.12M | $19.71 | OMERS Growth Equity, NewSpring Capital | ||||
 | Cybereason | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $851.87M | Series H | 3/10/2025 | $120M | $806.28M | $0.63 | SoftBank, Liberty Strategic Capital | ||||
 | Delphix | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $124.07M | Series D | 7/14/2015 | $75M | $1B | $9.00 | Fidelity Investments, Credit Suisse Asset Management, The Kraft Group, Greylock Partners, Lightspeed Venture Partners, Icon Ventures | ||||
 | Halo Investing | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119.79M | Series C | 10/12/2021 | $100M | $688.17M | $22.43 | Owl Capital, Mubadala, Allianz Life Ventures, William Blair Circle | ||||
 | Jellyfish | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $480.00K | -- | 1 | Not available | -- | -- | $113.41M | Series C | 2/1/2022 | $68.7M | $610.38M | $15.23 | Accel, Insight Partnres, Tiger Global Management, Wing Venture Capital | ||||
 | LinkSquares | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $161.48M | Series C | 4/4/2022 | $100M | $809.45M | $14.00 | G Squared, G2 Venture Partners, Hyperplane Venture Capital, MassMutual Ventures, First Ascent Ventures, Catalyst Investors, Xerox, Sorenson Capital | ||||
 | Maze Therapeutics | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $503.77M | Series D | 12/3/2024 | $76.4M | $552.39M | $1.38 | Frazier Life Sciences, Deep Track Capital, Janus Henderson Investors, Logos Capital | ||||
 | Novo | Fintech Digital Banking | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $169.88M | Series B-4 | 11/22/2022 | $35M | $720.19M | $24.74 | GGV Capital | ||||
 | ODF | Consumer & Lifestyle Social | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $101.44M | Series B | 9/1/2021 | $76.23M | $640.31M | $2.37 | Undisclosed Investors | ||||
 | Odyssey Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $413.6M | Series D | 9/10/2025 | $213.63M | $527.3M | $14.62 | Affinity Asset Advisors, Dimension Capital, Jeito Capital, Lightspeed Ventures, TPG, Wedbush Healthcare Partners | ||||
 | PopMenu | Consumer & Lifestyle Consumer & Lifestyle Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $88M | Series C | 6/11/2021 | $65M | $524.35M | $3.74 | Tiger Global Management, Salesforce Ventures, Bedrock Capital, Base10, Felicis Ventures | ||||
 | Propel | Fintech Personal Finance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $1.13M | -- | 1 | Not available | -- | -- | $91.41M | Series B | 4/8/2022 | $55.52M | $503.13M | $17.17 | Nyca Partners, Andreessen Horowitz, Kleiner Perkins, Flourish Ventures, JPMorgan, Salesforce Ventures, Mischief | ||||
 | Saliogen Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $156.22M | Series B | 1/5/2022 | $132.25M | $549.61M | $105.86 | GordonMD Global Investments, EPIQ Capital Group, Fidelity, T. Rowe Price, D1 Capital Partners, SymBiosis, Cystic Fibrosis Foundation, RD Fund | ||||
 | Shogun | Consumer & Lifestyle E-commerce Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $98.02M | Series C | 6/30/2021 | $57.5M | $569.62M | $20.43 | Insight Partners, Initialized Capital, Accel, VMG Partners | ||||
 | Shoreline Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $186M | Series B | 11/2/2021 | $140M | $527.99M | $10.07 | Ally Bridge Group, Eventide Asset Management, BeiGene, Irving Investors, Kingdon, NS Investment, Piper Heartland Healthcare Capital, Superstring, BVF Partners, Commodore Capital, Cormorant Asset Management, Janus Henderson Investors, Kite, Stork Capital, Wedbush Healthcare Partners | ||||
 | Silverfort | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $171.09K | -- | 1 | Not available | -- | -- | $223.34M | Series D | 1/23/2024 | $116.6M | $698.21M | $1.57 | Brighton Park Capital, Acrew Capital, Greenfield Partners, Citi Ventures, General Motors Ventures, Maor Investments, Vintage Investment Partners, Singtel Innov8 | ||||